Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (371-380 of 768) with videos related to

Pageof 77
Sort By:
Blood Cancer Journal|February 13, 2016
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trialJ J Shah, L Feng, S K Thomas, et al.
Leukemia & Lymphoma|October 14, 2010
Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemiaPaolo Anderlini, Sandra A Acholonu, Grace-Julia Okoroji, et al.
Experimental Hematology|January 17, 2004
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survivalIssa F Khouri, Ming-Sheng Lee, Rima M Saliba, et al.
Blood|June 15, 1994
BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapyJ Q Guo, J Y Lian, Y M Xian, et al.
Annals of Diagnostic Pathology|September 19, 2006
Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantationMalisha R Johnson, Daniel Del Carpio-Jayo, Pei Lin, et al.
Journal of Pain and Symptom Management|March 4, 2000
Management of cancer treatment-related diarrhea. Issues and therapeutic strategiesS Kornblau, A B Benson, R Catalano, et al.
Bone Marrow Transplantation|August 10, 2000
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)B S Andersson, J Gajewski, M Donato, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2004
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapyYee Chung Cheng, Gabriela Rondón, Ying Yang, et al.
Journal of Geriatric Oncology|March 14, 2018
Neurocognitive deficits in older patients with cancerBeatrice J Edwards, Xiaotao Zhang, Ming Sun, et al.
Blood|October 15, 1991
T-cell depletion of HLA-identical transplants in leukemiaA M Marmont, M M Horowitz, R P Gale, et al.
Pageof 77

Showing results (371-380 of 768) with videos related to

Sort By:
Pageof 77
Blood Cancer Journal|February 13, 2016
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trialJ J Shah, L Feng, S K Thomas, et al.
Leukemia & Lymphoma|October 14, 2010
Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemiaPaolo Anderlini, Sandra A Acholonu, Grace-Julia Okoroji, et al.
Experimental Hematology|January 17, 2004
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survivalIssa F Khouri, Ming-Sheng Lee, Rima M Saliba, et al.
Blood|June 15, 1994
BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapyJ Q Guo, J Y Lian, Y M Xian, et al.
Annals of Diagnostic Pathology|September 19, 2006
Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantationMalisha R Johnson, Daniel Del Carpio-Jayo, Pei Lin, et al.
Journal of Pain and Symptom Management|March 4, 2000
Management of cancer treatment-related diarrhea. Issues and therapeutic strategiesS Kornblau, A B Benson, R Catalano, et al.
Bone Marrow Transplantation|August 10, 2000
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)B S Andersson, J Gajewski, M Donato, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2004
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapyYee Chung Cheng, Gabriela Rondón, Ying Yang, et al.
Journal of Geriatric Oncology|March 14, 2018
Neurocognitive deficits in older patients with cancerBeatrice J Edwards, Xiaotao Zhang, Ming Sun, et al.
Blood|October 15, 1991
T-cell depletion of HLA-identical transplants in leukemiaA M Marmont, M M Horowitz, R P Gale, et al.
Pageof 77